August 25, 2022
RFA-DA-23-062 - NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
RFA-DA-23-061 - NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional).
RFA-DA-23-013: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) (nih.gov)
RFA-DA-23-023: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) (nih.gov)
RFA-DA-23-024: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) (nih.gov)
RFA-DA-23-025: NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) (nih.gov)
RFA-DA-23-026: NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) (nih.gov)
RFA-DA-23-028: NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (nih.gov)
RFA-DA-23-029: NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (nih.gov)
RFA-DA-23-031: NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional) (nih.gov)
RFA-DA-23-032: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) (nih.gov)
National Institute on Drug Abuse (NIDA)
This Notice provides information regarding an upcoming pre-application technical assistance (TA) webinar from the National Institute on Drug Abuse (NIDA) for applicants responding to NIDA Racial Equity Initiative Funding Opportunity Announcements.
The NIH is committed to supporting health equity research to 1) improve minority health and reduce health disparities in the United States and 2) remove the barriers to advancing health disparities research. In alignment with this NIH-wide effort, NIDA established the Racial Equity Initiative (REI). The NIDA REI Research Gaps and Opportunities (RGO) Workgroup convened a workshop in February, 2021 with a goal of identifying bold new directions for research to address racial and ethnic minority health disparities in substance use and addiction outcomes. In response to information gathered from this meeting and to internal and external discussions and listening sessions, NIDA has issued a suite of funding opportunity announcements, which include the following:
HIV and Substance Use:
Community Engaged Research:
Racial Equity Visionary Award:
Neurocognitive Mechanisms:
Coordination Center:
Pre-Application TA Webinar Information:
To provide guidance to the applicant community on the suite of REI funding opportunity announcements, a pre-application technical assistance webinar is scheduled for September 26, 2022 from 3:00 pm to 4:30 pm Eastern Time. Following an overview of the nine REI Funding Opportunity Announcements, NIDA staff will be available to answer programmatic, administrative, and review questions from prospective applicants. Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to the RFAs.
Attendees should register for the TA Webinar in advance at the following link: https://nih.zoomgov.com/webinar/register/WN_RpVclRPUQQWhR5T_guJLjQ. American Sign Language interpreting services are available upon request. Individuals who need interpreting services and/or other reasonable accommodations to participate in this event, should contact Dr. Vani Pariyadath ([email protected]) or the NIH Interpreting Office directly, via email, at [email protected]. Requests should be made at least five business days in advance in order to ensure interpreter availability.
Submitting questions for the webinar:
Prospective applicants are encouraged to contact program staff regarding questions about the RFAs at any time. Questions to be addressed during the webinar may be submitted through September 22, 2022 to the following mailbox: [email protected].
Additional information:
After the event, a recording of the webinar will be available for viewing at https://videocast.nih.gov/watch=45937, and a Frequently Asked Questions (FAQs) document will be posted on the NIDA Racial Equity Initiative Funding Priority website: https://nida.nih.gov/about-nida/racial-equity-initiative/funding-priorities.
Aria Crump, Sc.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-602-5312
Email: [email protected]
and Human Services (HHS)
